Evidence map›Paper›PMID 30745430›Full record

ArticleDevelopment (Cambridge, England)2019

The lineage-specific transcription factor CDX2 navigates dynamic chromatin to control distinct stages of intestine development.

Namit Kumar, Yu-Hwai Tsai, Lei Chen, Anbo Zhou, Kushal K Banerjee, Madhurima Saxena, Sha Huang, Natalie H Toke, Jinchuan Xing, Ramesh A Shivdasani and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Epigenetic Gatekeeping of Intestinal Stem Cell Transformation.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Primitive Hepatoblasts Driving Early Liver Development.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Namit KumarRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.ORCID 0000-0002-5084-3490
Yu-Hwai TsaiDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Lei ChenRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Anbo ZhouRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Kushal K BanerjeeDepartment of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Madhurima SaxenaDepartment of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Sha HuangDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Natalie H TokeRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Jinchuan XingRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Ramesh A ShivdasaniDepartment of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Jason R SpenceDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA spencejr@med.umich.edu Verzi@biology.rutgers.edu.ORCID 0000-0001-7869-3992
Michael P VerziRutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA spencejr@med.umich.edu Verzi@biology.rutgers.edu.ORCID 0000-0003-4082-4330
Rutgers, The State University of New Jersey · USBrigham and Women's Hospital · USUniversity of Michigan · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI STEVEN ZHENG · 1997 to 2026
$94.5M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiationR01DK082889 · NIDDK · DANA-FARBER CANCER INST · PI Ramesh A Shivdasani · 2010 to 2026
$5.2M
Niche support of human intestinal stem cellsU01DK103141 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPENCE, JASON · 2014 to 2023
$3.9M
Transcriptional Mechanisms of Tumor SuppressionR01CA190558 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI MICHAEL P. VERZI · 2015 to 2026
$3.6M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
CDX2 regulation of anti-repressive enhancers in intestinal epitheliumF32DK115080 · NIDDK · DANA-FARBER CANCER INST · PI SAXENA, MADHURIMA · 2017 to 2019
$145k
NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA190558NIDDK NIH HHS F32 DK115080NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R01 DK082889NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK103141NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

Lineage-restricted transcription factors, such as the intestine-specifying factor CDX2, often have dual requirements across developmental time. Embryonic loss of CDX2 triggers homeotic transformation of intestinal fate, whereas adult-onset loss compromises crucial physiological functions but preserves intestinal identity. It is unclear how such diverse requirements are executed across the developmental continuum. Using primary and engineered human tissues, mouse genetics, and a multi-omics approach, we demonstrate that divergent CDX2 loss-of-function phenotypes in embryonic versus adult intestines correspond to divergent CDX2 chromatin-binding profiles in embryonic versus adult stages. CDX2 binds and activates distinct target genes in developing versus adult mouse and human intestinal cells. We find that temporal shifts in chromatin accessibility correspond to these context-specific CDX2 activities. Thus, CDX2 is not sufficient to activate a mature intestinal program; rather, CDX2 responds to its environment, targeting stage-specific genes to contribute to either intestinal patterning or mature intestinal function. This study provides insights into the mechanisms through which lineage-specific regulatory factors achieve divergent functions over developmental time.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCDX2 Transcription FactorCell DifferentiationCell LineageChromatinCRISPR-Cas SystemsFemaleHomeodomain ProteinsHumansIntestinal MucosaIntestinesMiceMice, KnockoutMutationPluripotent Stem CellsCDX2 protein, humanCdx2 protein, mouseCDX2 Transcription FactorChromatinHomeodomain ProteinsTrans-ActivatorsChromatinDevelopmentIntestineLineage-specifyingPatterningTranscription factor

Identifiers

PMID30745430
PMCPMC6432663
OpenAlexW2952452404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.